Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
INDUSTRY
×
Respiratory Tract Diseases
×
Erlotinib Hydrochloride
×
Clear all
Filters
3
NCT03653546
2025-09-10
BM
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 2/3
Completed
492 enrolled
NCT01594398
2021-11-19
ENCORE110
Syndax Pharmaceuticals
Phase 1
Completed
14 enrolled
NCT02134015
2018-01-23
HER3-Lung
Daiichi Sankyo
Phase 3
Terminated
145 enrolled
20 charts